Component | Classification | Main roots | Test models | Dose | Mechanisms | Specific effects | Refs. |
---|---|---|---|---|---|---|---|
Solasonine | Alkaloids | Solanum nigrum L. | Calu-1 and A549 cells | In vitro: 10, 15, 20 μM (calu-1); 20, 25, 30 μM (A549) | Causing GSH redox system imbalance and mitochondrial oxidative stress | Causing iron overload and redox imbalance; lipid peroxidation; mitochondrial damage; the destruction of the GSH redox system: decreasing expression of GPX4, SLC7A11, GSH, and Cys; MMP hyperpolarization | [74] |
Erianin | Phenols | Dendrobium | H460 and H1299 cells; Balb/c nude mice | In vitro: 12.5, 25, 50, 100Â nm; In vivo: 100Â mg/kg | Inducing Ca2+/ CaM signal pathway | Promoting cell cycle arrest in G2/M; activating CAM and regulating L-type voltage-dependent Ca2+ channels; lipid peroxidation; promoting the production of ROS, MDA, TRF; decreasing expression of GPX4, CHAC2, SLC40A1, SLC7A11, HO-1, GSH | [75] |
Diplacone | Flavonoids | Paulownia tomentosa mature fruit | A549 cells | In vitro: 40 μM | Increasing mitochondrial Ca2+ Influx and MPTP | Increasing the level of intracellular Ca2+, mitochondrial ROS, and mitochondrial Ca2+ overload; increasing the opening of the VDAC and MPTP; inducing loss of MMP; lipid peroxidation | [76] |
Qingrehuoxue Formula | Formulas | Chinese herbal medicine | male Balb/c nude mice | In vivo: 15 g/kg | Upregulating P53 and GSK-3β and downregulating Nrf2 signal pathways | Increasing the levels of intracellular ROS, Fe2+, H2O2, GSH and MDA↑; decreasing the expression of SLC7A11, GPX4; shrunking mitochondria with increasing membrane density and decreasing or disappearing mitochondrial cristae | [78] |
Bufotalin | Steroids | Venenum bufonis | A549 cells; male Balb/c nude mice | In vitro: 4 μM; In vivo: 5/10 mg/kg | Facilitating the ubiquitination and degradation of GPX4 | Increasing the level of lipid ROS, 4-HNE, MDA, Fe2 + ; decreasing the ratio of GSH/GSSG and NADPH/NADP +  | [32] |
Dihydroisotans-hinone I | Quinones | Salvia miltiorrhiza Bunge | A549, H460 and IMR-90 cells; xenograft nude mice | In vitro: 20–30 μM; In vivo: 30 mg/kg | Blocking the protein expression of GPX4 | Increasing the level of lipid ROS and MDA; decreasing expression of GPX4 and GSH | [80] |
Sanguinarine | Alkaloids | Sanguinaria canadensis Linn | A549 and H3122 cells; xenograft mice | In vitro: 10 μM; In vivo: 5 mg/kg | Decreasing the protein stability of GPX4 through E3 ligase STUB1-mediated ubiquitination and degradation of GPX4 | Increasing Fe2+ concentration, ROS level, and MDA content; decreasing GSH content | [81] |
Red ginseng polysaccharide | Polysaccharides | Panax ginseng | A549 and MDA-MB-231 cells | In vitro: 200 μg/ml | Blocking the protein expression of GPX4 | Increasing the release of LDH and the level of lipid ROS; decreasing expression of GPX4 | [82] |
Timosaponin AIII | Steroids | Anemarrhena Asphodeloides Bunge | H1299, A549, SPC-A1 and LLC cells; male C57BL/6 J or Balb/c- nude mice | In vitro: 4 μM; In vivo: 12.5 mg/kg (low-dose), 50 mg/kg (high-dose) | Facilitating HSP90 mediated GPX4 ubiquitination and degradation | Suppressing cell proliferation and migration, inducing G2/M phase arrest; increasing the levels of iron, lipid ROS, MDA, HMOX-1; decreasing expression of GSH, FTL, GPX4, SLC40A1, SLC7A11; inducing loss of MMP | [83] |
Zerumbone | Terpenoids | Zingiber zerumbet rhizomes | HPAEpiC, A549, and H460 cell; BALB/c nude mice | In vitro: 100 μM; In vivo: 20 mg/kg (low-dose), 40 mg/kg (high-dose) | Downregulating AKT/STAT3/SLC7A11 axis | Increasing the level of MDA; decreasing the levels of GSH, GPX4 and SLC7A11 | [86] |
S-3′-hydroxy-7′, 2′, 4′-Trimethoxyisoxane | Flavonoids | Dalbergia odorifera T. Chen | A549 and H460 cells; Balb/c nude mice | In vitro: 16 μM; In vivo: – | Inhibiting Nrf2/HO-1 signaling pathway | Increasing the level of Fe2 + , ROS and MDA; decreasing the levels of GSH, GPX4, p21, FTH1, Nrf2, HO-1; TEM: cell membrane rupture, mitochondrial shrinkage, thickening of the mitochondrial membrane density, and diminished or disappeared mitochondrial ridges | [88] |
Ginkgetin | Flavonoids | Ginkgo biloba leaves | Xenograft nude mice | In vitro: 5 μM; In vivo: 30 mg/kg | Inhibiting Nrf2/HO-1 signaling pathway | Increasing labile iron pool and lipid peroxidation; decreasing expression of SLC7A11, GPX4, GSH; inducing loss of MMP | [89] |
Manoalide | Terpenoids | Sponges | A549, H157, HCC827, and PC9 cells | In vitro: 15 μM | Suppressing the KRAS-ERK pathway and the Nrf2-SLC7A11 axis, mitochondrial Ca2 + overload induced-FTH1 pathways | Inducing ER stress; promoting the accumulation of lipid droplets, ROS, lipid peroxidation, mitochondria Ca2 + and iron; increasing the oxygen consumption rate and inhibiting mitochondria fatty acid oxidation; decreasing expression of Nrf2, SLC7A11, FTH1, GPX4, KRAS, P-ERK/ERK; increasing expression of NCOA4 and P-AMPK/AMPK | [90] |
Hedyotisdiffusa injection | Other | Chinese herbal medicine | A549 and H1975 cells; Balb/c nude mice xenograft model | In vitro: 30 μM (A549), 40 μM (H1975); In vivo: 15 mg/kg | Regulating Bax/Bcl2/VDAC2/3 axis | Regulating VDAC2/3 activity by promoting Bax via inhibiting Bcl2; increasing the expression of 4-HNE, TFR, and HMOX1 | [91] |
D-Borneol | Terpenoids | Cinnamomum cam phora (L.) J. Presl | H460/CDDP cells; Xenograft tumor mice | In vitro: 2 μg/ml; In vivo: 30 mg/kg (low-dose), 60 mg/kg (high-dose) | Promoting NCOA4-mediated ferritinophagy | Increasing the level of ROS, MDA; decreasing expression of GSH, SOD, Trx, HO-1 | [92] |
Artesunate | Terpenoids | Artemisinin | NCI-H1299, A549, LTEP-a-2, NCI-H23, and NCI-H358 cells | In vitro: 10/30 μM | Inhibiting system Xc −  and activating TFRC | Increasing the ROS level and the mRNA level of TFRC; decreasing the protein level of VDAC and SLC7A11; | [93] |
Dihydroartemisinin | Terpenoids | Artemisinin | NCI-H1299, A549, LTEP-a-2, NCI-H23, and NCI-H358 cells | In vitro: 10/30 μM | Inhibiting system xc −  and activating TFRC | Increasing the ROS level and the mRNA level of TFRC; decreasing the protein level of VDAC and SLC7A11; | [93] |
Curcumenol | Terpenoids | Wenyujin | CCD19, H1299, H460, BEAS-2B and 293 T cells | In vitro: 300 μg/ml; In vivo: 200 mg/kg | Suppressing lncRNA H19/miR-19b-3p/FTH1 axis | Increasing the level of iron, lipid ROS, HO-1, MDA, TF; decreasing the level of GSH, Nrf2, GPX4, SLC7A11, SLC40A1, FTH1 | [96] |
Sulforaphane | Glycosides | Cruciferous vegetables | NCI-H69, NCI-H82 and NCI-H69AR cells | In vitro: 20 μM | Inhibiting system Xc −  | Decreasing the level of SLC7A11, GSH; increasing the level of Fe2 + , lipid peroxidation | [97] |
Sinapine | Alkaloids | Rapeseed and cruciferous plant species | A549, SK, H66, H460 and HBE cells | In vitro: 20 μM | Upregulating p-53,TF, TFRC; downregulating SLC7A11 | Increasing intracellular ferrous iron, lipid peroxidation, MDA and ROS; decreasing the expression of SLC7A11, GSH, GPX4 | [101] |
HO-3867 | Other | Curcumin analogs | H460, PC-9, H1975, A549, H1299, A549 p53 KO cells and H460 p53 KO cells | In vitro: 40 μM | Activating the p53-DMT1 axis and suppressing GPX4 | Increasing the level of iron, ROS; increasing expression of P53, DMT1; decreasing expression of SLC7A11, GPX4 | [102] |
6-Gingerol | Phenols | Ginger | A549 and CCD19-Lu cells; Balb/c nude mice | In vitro: 20, 40, 80 μM; In vivo: 0.25 mg/kg (low-dose), 0.5 mg/kg (high-dose) | Inhibiting USP14-mediated Beclin1 ubiquitination, enhancing autophagy-dependent ferroptosis | Increasing level of MDA, iron and TfR1; decreasing level of USP14, FTH1, GPX4, ATF4, SOD; increasing autophagy related proteins level of Beclin- 1, NCOA4, LC3 I, LC3 II | [103] |
Realgar | Other | Sulfide minerals | H23 cells | In vitro: 2 μg/ml | Suppressing the KRAS/Raf/MAPK pathway | Increasing the level of MDA, Fe2 + , ROS; decreasing expression of GSH; inducing loss of MMP | [106] |
Curcumin | Phenols | Turmeric plant | A549 and H1299 cells; female C57BL/6 mice | In vitro: 30 μM; In vivo: 100 mg/kg | Activating autophagy-dependent ferroptosis | Increasing the level of iron, lipid peroxidation, ROS, MDA, IREB2, ACSL4; decreasing the level of SOD, GSH, SLC7A11, GPX4; inducing mitochondrial membrane rupture; decreasing mitochondrial cristae; increasing autolysosome; increasing autophagy related proteins level of Beclin1 and LC3, and decreasing the level of P62 | [108] |
Resveratrol | Phenols | Peanuts, grapes, knotweed, mulberries | H520 cells | In vitro: 50 μmol/L; | Regulating SLC7A11-HMMR interaction, enhancing the cytotoxic effect of CD8 + T cells | Increasing the level of MDA, ACSL4, TFRC; decreasing the level of GPX4, SLC7A11, HMMR, GSH, and SOD; promoting the release of TNF-α, IFN-γ, IL-12, and IL-2; enhancing the cytotoxic effects of CD8 + T cells | [111] |
Resveratrol | Phenols | Peanuts, grapes, knotweed, mulberries | BEAS-2B cells | In vitro: 10 μM; | Activating the Nrf2/Keap1 signaling pathway | Decreasing reactive oxygen species production and iron deposition; increasing the expression of GPX4 and GSH | [112] |